Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations are in order for Professor Damian Tyler, who has been awarded a renewal of his British Heart Foundation Senior Fellowship. The award will fund a project designed to develop a new imaging approach, enabling doctors to diagnose heart diseases more accurately.

Damian Tyler has been awarded a renewal of his BHF Senior Fellowship for his research "Building an Imaging Toolbox for Metabolic Heart Disease." The award will fund his lab for the next five years and enable his team to improve diagnostic imaging in heart disease.

The heart requires a huge amount of energy to beat non-stop for the whole of a person's life. When the heart becomes diseased, it is often because something has gone wrong with the way the heart turns the fuels we eat into the energy it needs to beat.

A new approach, called Hyperpolarized magnetic resonance imaging (MRI), allows us to make images that shows exactly how the heart is making this energy from sugars and these images can be used to understand what has gone wrong in certain diseases, such as diabetes and heart attacks. 

Damian's project will aim to improve hyperpolarized MRI to make the images clearer and faster. His research will also allow images to be made that show us how the heart uses other fuels, such as fats. These improvements will help doctors to more accurately diagnose heart diseases and to monitor how patients respond to treatments.

 

I'm delighted to have had my fellowship renewed by the BHF. Their continued support has allowed us to take this exciting new imaging technology from basic principles through to first-in-man trials in patients. We are looking forward to working hard to translate these approaches to make a difference to the clinical care of patients with a wide range of heart diseases. - Professor Damian Tyler

 

Similar stories

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.

BHF Senior Fellowship renewal for Duncan Sparrow could pave the way to revealing unknown causes of heart defects in babies

Congratulations are in order for Associate Professor Duncan Sparrow, who has been awarded a renewal of his British Heart Foundation Senior Basic Science Research Fellowship. The award will fund crucial investigations into little understood environmental risk factors of congenital heart disease, and could one day lead to new therapeutic strategies.

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.